Hypertonic Saline for the Treatment of Bronchiolitis in Infants and Young Children: A Critical Review of the Literature
- 1 January 2016
- journal article
- review article
- Published by Pediatric Pharmacy Advocacy Group in The Journal of Pediatric Pharmacology and Therapeutics
- Vol. 21 (1), 7-26
- https://doi.org/10.5863/1551-6776-21.1.7
Abstract
Bronchiolitis, an infection of the lower respiratory tract, is the leading cause of infant and child hospitalization in the United States. Therapeutic options for management of bronchiolitis are limited. Hypertonic saline inhalation therapy has been studied in numerous clinical trials with mixed results. In 2014, the American Academy of Pediatrics (AAP) published updated guidelines on the diagnosis and management of bronchiolitis, which include new recommendations on the use of hypertonic saline. We reviewed all published clinical trials mentioned in the 2014 AAP guidelines, as well as additional trials published since the guidelines, and critically evaluated each trial to determine efficacy, safety, and expectations of hypertonic saline inhalation therapy. A total of 2682 infants were studied over the course of 22 clinical trials. Nine trials were carried out in the outpatient/clinic/emergency department and 13 in the inpatient setting. We agree with the AAP guidelines regarding the recommendation to use nebulized hypertonic saline for infants hospitalized with bronchiolitis, with the expectation of reducing bronchiolitis scores and length of stay when it is expected to last more than 72 hours. However, we also believe there might be an advantage for hypertonic saline in reducing admission rates from the emergency department, based on close examination of the results of recent trials. This review also highlights important gaps in the available literature that need to be addressed in order to define the role of inhaled hypertonic saline therapy.Keywords
This publication has 51 references indexed in Scilit:
- Hypertonic (3%) saline Vs 0.9% saline nebulization for acute viral bronchiolitis: A randomized controlled trialIndian Pediatrics, 2013
- The efficacy of nebulized salbutamol, hypertonic saline and salbutamol/hypertonic saline combination in moderate bronchiolitisPulmonary Pharmacology & Therapeutics, 2011
- Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitisClinical Microbiology & Infection, 2011
- Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysisBMJ, 2011
- Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitisPediatrics International, 2010
- Hypertonic saline or high volume normal saline for viral bronchiolitis: Mechanisms and rationalePediatric Pulmonology, 2009
- High volume normal saline alone is as effective as nebulized salbutamol‐normal saline, epinephrine‐normal saline, and 3% saline in mild bronchiolitisPediatric Pulmonology, 2009
- Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infantsArchives of Disease in Childhood, 2009
- Nebulised hypertonic saline for cystic fibrosisEmergencias, 2009
- Short acting beta2-agonists for recurrent wheeze in children under two years of ageEmergencias, 2002